| Item Type | Name |
|
Concept
|
Affect
|
|
Concept
|
Age Factors
|
|
Concept
|
Administration, Inhalation
|
|
Concept
|
Blood Pressure
|
|
Concept
|
Administration, Intranasal
|
|
Concept
|
Administration, Oral
|
|
Concept
|
Administration, Sublingual
|
|
Concept
|
Cardiac Output
|
|
Concept
|
Anesthetics, Dissociative
|
|
Concept
|
Central Nervous System Stimulants
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Appetite
|
|
Concept
|
Deuterium
|
|
Concept
|
Choice Behavior
|
|
Concept
|
Body Temperature
|
|
Concept
|
Bicycling
|
|
Concept
|
Cerebellum
|
|
Concept
|
Central Nervous System Depressants
|
|
Concept
|
Cognition
|
|
Concept
|
Buprenorphine
|
|
Concept
|
Hallucinations
|
|
Concept
|
Hormones
|
|
Concept
|
Dextromethorphan
|
|
Concept
|
Dehydroepiandrosterone
|
|
Concept
|
Emotions
|
|
Concept
|
Dextroamphetamine
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Drug Administration Routes
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Dopamine
|
|
Concept
|
Drug Combinations
|
|
Concept
|
Hydrocortisone
|
|
Concept
|
Language
|
|
Concept
|
Lysergic Acid Diethylamide
|
|
Concept
|
Pharmacogenetics
|
|
Concept
|
Narcotics
|
|
Concept
|
Hallucinogens
|
|
Concept
|
Oxytocin
|
|
Concept
|
Methamphetamine
|
|
Concept
|
Health Policy
|
|
Concept
|
Hematuria
|
|
Concept
|
Ketamine
|
|
Concept
|
Naloxone
|
|
Concept
|
Narcotic Antagonists
|
|
Concept
|
Oxygen
|
|
Concept
|
Psychomotor Performance
|
|
Concept
|
Risk Factors
|
|
Concept
|
Visual Perception
|
|
Concept
|
3,4-Methylenedioxyamphetamine
|
|
Concept
|
Serotonin
|
|
Concept
|
Hemodynamics
|
|
Concept
|
Task Performance and Analysis
|
|
Concept
|
Humans
|
|
Concept
|
Informed Consent
|
|
Concept
|
Injections, Intravenous
|
|
Concept
|
Stroke Volume
|
|
Concept
|
Receptors, Opioid, kappa
|
|
Concept
|
Nasal Decongestants
|
|
Concept
|
Urologic Diseases
|
|
Concept
|
Vision, Ocular
|
|
Concept
|
Echocardiography, Doppler
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Glutamic Acid
|
|
Concept
|
Morphine
|
|
Concept
|
Weight Gain
|
|
Concept
|
Rats, Sprague-Dawley
|
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Disclosure
|
|
Concept
|
Self Report
|
|
Concept
|
Consensus
|
|
Concept
|
Diterpenes, Clerodane
|
|
Concept
|
Diagnostic and Statistical Manual of Mental Disorders
|
|
Concept
|
Area Under Curve
|
|
Concept
|
Prolactin
|
|
Concept
|
Mice
|
|
Concept
|
Dysuria
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Athletic Performance
|
|
Concept
|
Norepinephrine Plasma Membrane Transport Proteins
|
|
Concept
|
Rats
|
|
Concept
|
Antipsychotic Agents
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Urinalysis
|
|
Concept
|
N-Methyl-3,4-methylenedioxyamphetamine
|
|
Concept
|
Nootropic Agents
|
|
Concept
|
Cardiovascular Physiological Phenomena
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Data Collection
|
|
Concept
|
Data Interpretation, Statistical
|
|
Concept
|
Delayed-Action Preparations
|
|
Concept
|
Heart Rate
|
|
Concept
|
Norepinephrine
|
|
Concept
|
Papio
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Psychotropic Drugs
|
|
Concept
|
Speech
|
|
Concept
|
Terpenes
|
|
Concept
|
Ethics, Clinical
|
|
Concept
|
Dopamine Plasma Membrane Transport Proteins
|
|
Concept
|
Medication Adherence
|
|
Academic Article
|
Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers.
|
|
Academic Article
|
More about parkinsonism after taking ecstasy.
|
|
Academic Article
|
Chemical analysis of ecstasy pills.
|
|
Academic Article
|
Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial.
|
|
Academic Article
|
Caveat emptor: editors beware.
|
|
Academic Article
|
Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
|
|
Academic Article
|
Preventing problems in Ecstasy users: reduce use to reduce harm.
|
|
Academic Article
|
Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose.
|
|
Academic Article
|
Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans.
|
|
Academic Article
|
Efficacy, safety, and ethics of cosmetic neurology far from settled.
|
|
Academic Article
|
A method to quantify illicit intake of drugs from urine: methamphetamine.
|
|
Academic Article
|
The effects of inhaled L-methamphetamine on athletic performance while riding a stationary bike: a randomised placebo-controlled trial.
|
|
Academic Article
|
Imagery scripts and a computerized subtraction stress task both induce stress in methamphetamine users: a controlled laboratory study.
|
|
Academic Article
|
Test-retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention.
|
|
Academic Article
|
MDMA effects consistent across laboratories.
|
|
Academic Article
|
Intimate insight: MDMA changes how people talk about significant others.
|
|
Academic Article
|
Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting.
|
|
Academic Article
|
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?
|
|
Academic Article
|
Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers.
|
|
Academic Article
|
Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing.
|
|
Concept
|
Cannabinoid Receptor Modulators
|
|
Academic Article
|
Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine.
|
|
Academic Article
|
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement.
|